Brendan M. Giles, PhD

The University of Pittsburgh provided a unique opportunity to investigate immunology of infectious disease using emerging pathogens. Developing vaccines for highly pathogenic viruses is exciting and translates directly to improving human health. The outstanding faculty and state-of-the-art facilities combine to create an environment that fosters independent thought and collaboration, which have been essential to my growth as a scientist.

Following his graduation from the University of Pittsburgh, Brendan accepted a position as a Postdoctoral Fellow at the University of Colorado in the Department of Rheumatology.

Book Chapters

Ross TM, Bhardwaj N, Eugene HS, Giles BM, McBurney SP, Rossi SL, Schneider-Ohrum K, Tang X. "Virus Like-Particle Vaccines: Advantages and Challenges" Development of Vaccines: From Discover to Clinical Testing. 2009. Wiley and Sons (USA)

Abstracts

Giles BM, Bissel SJ, Wiley CA, Ross TM. 2011. Computationally Optimized Broadly Reactive Antigen (COBRA): A novel strategy for developing a broadly reactive vaccine against H5N1 influenza.  Vaccines Against Emerging Infectious Diseases. Montego Bay, Jamaica. Oral Presentation.

Giles BM, Ross TM. 2010. Elicitation of broadly reactive immune responses using a consensus H5N1 virus-like particle. American Society for Virology: 29th Annual Meeting. Bozeman, MT. Oral presentation.

Giles BM, Tumpey TM, Ross TM. 2010. Elicitation of Protective Immune Responses to Swine Origin H1N1 Using a 1918 Virus-Like Particle. Swine Origin H1N1 Virus: The First Pandemic of the 21st Century. Atlanta, GA. Poster Session.

Giles BM, Crevar CJ, Tumpey TM, Ross TM. 2009. Elicitation of protective immune responses using a 1918 influenza virus-like particle. 7th Biodefense and Emerging Diseases Research Meeting. Baltimore, MD.  Oral presentation.